RecruitingNot ApplicableNCT03535142

Prognostic Significance of Fatty Liver Disease in Bariatric Patients

Sponsor

Esbjerg Hospital - University Hospital of Southern Denmark

Enrollment

1,200 participants

Start Date

Aug 15, 2018

Study Type

INTERVENTIONAL

Conditions

Non-Alcoholic Fatty Liver Disease Non Alcoholic Steatohepatitis Obesity, Morbid Metabolic Encephalopathy

Summary

Prospective non-randomized intervention case control study on patients with a BMI \> 35. The intervention group/cases (n=600) is comprised of bariatric patients who undergo bariatric surgery and the control group (n=600) of age, weight and comorbidity matched patients who choose not to undergo bariatric surgery. The overall aim is to examine prevalence of the spectrum of fatty liver disease (NAFLD) in these patients and the prognostic significance of NAFLD.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Bariatric surgery for people with metabolic encephalopathy, non alcoholic steatohepatitis, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBariatric surgery

Roux en y gastric bypass or gastric sleeve operation

Locations(1)

Hospital of Southwest Jutland

Esbjerg, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03535142

Related Trials

Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

NCT038840751 location

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

NCT0692004330 locations